VEERAM SECURITIES LIMITED (VSL.BO)
INR 10.41
(-1.05%)
INR 10.41
(-1.05%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.21 Million | 7.29 Million | 39.43 Million | -95.54 Million | 41.53 Million | 31.05 Million |
| Net Income | 24.61 Million | 17.89 Million | 39.85 Million | 29.29 Million | 10.92 Million | 3.06 Million |
| Depreciation & Amortization | 228.14 Thousand | 501 Thousand | 253.4 Thousand | 1.43 Million | 623.45 Thousand | 23.94 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -24.07 Million | -12.76 Million | 21.84 Million | -94.28 Million | 34.47 Million | 26.88 Million |
| Other non-cash items | -1.98 Million | 16.56 Million | -17.97 Million | 47.27 Million | -35.12 Million | -25.78 Million |
| Investing Cash Flow | 1.92 Million | -7.71 Million | -56.55 Million | 90.27 Million | 13.88 Million | -14.09 Million |
| Investments in PPE | -3000.00 | -6.04 Million | -81.45 Million | - | -54.38 Million | - |
| Acquisitions | 225 Thousand | - | - | 29.13 Million | - | - |
| Investment purchases | - | - | - | - | - | -14.09 Million |
| Sales/Maturities of investments | - | - | 1.97 Million | 29.21 Million | 6.51 Million | - |
| Other Investing Activities | 1.92 Million | -1.66 Million | 22.93 Million | 31.91 Million | 7.37 Million | -11.78 Million |
| Financing Cash Flow | -7771.00 | -5.02 Million | -8740.00 | -530.91 Thousand | -7.41 Million | 7.33 Million |
| Debt repayment | - | - | - | - | -7.41 Million | -7.37 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 57.75 Million | - | - |
| Other Financing Activities | -7771.00 | -5.02 Million | -8740.00 | -58.28 Million | -7.41 Million | -39 Thousand |
| Accounts receivables | - | - | - | 3.56 Million | -3.56 Million | - |
| Accounts payables | 87 Thousand | 89 Thousand | 800 Thousand | -91.26 Million | 31.87 Million | 32.73 Million |
| Inventory | 2.26 Million | -13.98 Million | -4.82 Million | 11.31 Million | -13.02 Million | -5.82 Million |
| Other working capital | -26.34 Million | 1.13 Million | 25.87 Million | -17.89 Million | 2.59 Million | -22.6 Thousand |
| Cash at beginning of period | 2.08 Million | 839.83 Thousand | 17.95 Million | 23.75 Million | 58.74 Million | 34.44 Million |
| Cash at end of period | 2.78 Million | 2.08 Million | 839.83 Thousand | 17.95 Million | 23.75 Million | 58.74 Million |
| Capital Expenditure | -3000.00 | -6.04 Million | -81.45 Million | - | -54.38 Million | - |
| Effect of forex changes on cash | - | 6.67 Million | 8737.00 | -2.00 | -83 Million | -64.00 |
| Net cash flow / Change in cash | 705.69 Thousand | 1.24 Million | -17.11 Million | -5.79 Million | -34.99 Million | 24.29 Million |
| Free Cash Flow | -1.21 Million | 1.24 Million | -42.01 Million | -95.54 Million | -12.85 Million | 31.05 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 10.11 Million | 24.61 Million | 9.75 Million | 4.28 Million | 5.1 Million | 5.46 Million |
| Depreciation & Amortization | - | 228 Thousand | - | 148 Thousand | 110 Thousand | 118 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -24.34 Million | - | - | - | - |
| Other non-cash items | -10.11 Million | 32 Thousand | -9.75 Million | -4.28 Million | -5.1 Million | -5.46 Million |
| Investing Cash Flow | - | -1.7 Million | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | 225 Thousand | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -1.92 Million | - | - | - | - |
| Financing Cash Flow | - | - | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | 87 Thousand | - | - | - | - |
| Inventory | - | 2.26 Million | - | - | - | - |
| Other working capital | - | -26.69 Million | - | - | - | - |
| Cash at beginning of period | - | 2.08 Million | - | 494 Thousand | -4.61 Million | 2.08 Million |
| Cash at end of period | - | 2.78 Million | - | 790 Thousand | 494 Thousand | 5.46 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | 706 Thousand | - | 296 Thousand | 5.1 Million | 3.38 Million |
| Free Cash Flow | - | 2.43 Million | - | 296 Thousand | 5.1 Million | 5.46 Million |
FMCCI
FLXI
PPG
AJANTPHARM
SMAYF
SHO